Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 19, 2009
[Lung cancer]
Hideaki Mizutani, Akihiko Gemma
Immunotherapy
|
April 22, 2020
Reactivation of TB during administration of durvalumab after chemoradiotherapy for non-small-cell lung cancer: a case report
Yasuhiro Kato, Yasutaka Watanabe, Yuki Yamane, et al.
Molecular Cancer Therapeutics
|
November 22, 2013
MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells
Kazuhiro Kitamura, Masahiro Seike, Tetsuya Okano, et al.
International Journal of Clinical Oncology
|
March 4, 2021
Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations
Yasuhiro Kato, Gou Yamamoto, Yasutaka Watanabe, et al.
International Journal of Oncology
|
July 4, 2012
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells
Mengru Cao, Masahiro Seike, Chie Soeno, et al.
Oncology Letters
|
August 8, 2012
HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner
Hideaki Mizutani, Tetsuya Okano, Yuji Minegishi, et al.
Future Oncology (London, England)
|
January 17, 2022
Uncommon <i>EGFR</i> mutations conducted with osimertinib in patients with NSCLC: a study protocol of phase 2 study (UNICORN/TCOG1901)
Yusuke Okuma, Mototsugu Shimokawa, Kana Hashimoto, et al.
Japanese Journal of Clinical Oncology
|
May 11, 2016
Interstitial lung disease associated with amrubicin chemotherapy in patients with lung cancer: a single institutional study
Yukiko Miura, Yoshinobu Saito, Kenichiro Atsumi, et al.
Anticancer Research
|
October 13, 2012
Combination chemotherapy of alternating etoposide and carboplatin with weekly administration of irinotecan and cisplatin in extensive-stage small-cell lung cancer
Akinobu Yoshimura, Rintaro Noro, Akihiko Miyanaga, et al.
Experimental and Therapeutic Medicine
|
November 9, 2012
Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panel
Mitsunori Hino, Kuniko Matsuda, Akihiko Miyanaga, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 19, 2009
[Lung cancer]
Hideaki Mizutani, Akihiko Gemma
Immunotherapy
|
April 22, 2020
Reactivation of TB during administration of durvalumab after chemoradiotherapy for non-small-cell lung cancer: a case report
Yasuhiro Kato, Yasutaka Watanabe, Yuki Yamane, et al.
Molecular Cancer Therapeutics
|
November 22, 2013
MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells
Kazuhiro Kitamura, Masahiro Seike, Tetsuya Okano, et al.
International Journal of Clinical Oncology
|
March 4, 2021
Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations
Yasuhiro Kato, Gou Yamamoto, Yasutaka Watanabe, et al.
International Journal of Oncology
|
July 4, 2012
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells
Mengru Cao, Masahiro Seike, Chie Soeno, et al.
Oncology Letters
|
August 8, 2012
HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner
Hideaki Mizutani, Tetsuya Okano, Yuji Minegishi, et al.
Future Oncology (London, England)
|
January 17, 2022
Uncommon <i>EGFR</i> mutations conducted with osimertinib in patients with NSCLC: a study protocol of phase 2 study (UNICORN/TCOG1901)
Yusuke Okuma, Mototsugu Shimokawa, Kana Hashimoto, et al.
Japanese Journal of Clinical Oncology
|
May 11, 2016
Interstitial lung disease associated with amrubicin chemotherapy in patients with lung cancer: a single institutional study
Yukiko Miura, Yoshinobu Saito, Kenichiro Atsumi, et al.
Anticancer Research
|
October 13, 2012
Combination chemotherapy of alternating etoposide and carboplatin with weekly administration of irinotecan and cisplatin in extensive-stage small-cell lung cancer
Akinobu Yoshimura, Rintaro Noro, Akihiko Miyanaga, et al.
Experimental and Therapeutic Medicine
|
November 9, 2012
Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panel
Mitsunori Hino, Kuniko Matsuda, Akihiko Miyanaga, et al.
Page
of 3